Development and Maintenance of Lens Transparency
Development and Maintenance of Lens Transparency
批准号:
7915853
负责人:
JOHN Irwin CLARK
金额:
$19.42万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-01 至 2011-08-31
关键词:
AccountingAddressAffinityAgeAge related macular degenerationAgingAmyloidAmyloid ProteinsAmyloidosisAnimalsBindingBiological AssayBiological MarkersBiomedical ResearchBrainCardiomyopathiesCardiovascular DiseasesCataractCellsCellular StructuresChimeric ProteinsClassificationCrystalline LensCrystallinsCytoskeletal ProteinsDepositionDevelopmentDiseaseDissociationElectron MicroscopyFilamentHeat shock proteinsHumanImageIn VitroIndividualInvestigationLens FiberLifeLightLinkLiteratureLongevityMaintenanceMass Spectrum AnalysisMeasuresMediatingMicroscopicModelingModificationMolecular ChaperonesMuscular DystrophiesNerve DegenerationNervous system structureNeuromuscular DiseasesNeuronsOpticsPeptidesPhenotypePhylogenetic AnalysisProteinsPublic HealthResearchSamplingStructural ProteinStructureTestingTherapeuticTissuesToxic effectTransgenic Miceaging brainamyloid fibril formationamyloid formationbasebiological adaptation to stressimmunocytochemistryin vitro testingin vivoinnovationinsightlaser capture microdissectionlenslens transparencylight scatteringmouse modelmutantnew therapeutic targetnovelnovel therapeuticsprotective effectprotein Bprotein aggregateprotein protein interactionpublic health relevancestress proteinsynthetic peptide
中文摘要
描述(由申请人提供):拟议研究的主要目标是确定应激蛋白、人?B晶体蛋白、小分子热休克蛋白(SHSP)和分子伴侣的保护作用的作用机制。假设1:人类β?B晶体蛋白中的多个相互作用序列的活性提供了保护,防止蛋白质在包括白内障、神经变性、AMD以及可能的神经肌肉疾病在内的衰老疾病中的展开、聚集和毒性。基于βB晶状体蛋白中单个相互作用结构域的合成肽介导淀粉样纤维的形成,并将用于表征相互作用结构域在βB晶状体蛋白作用中的集体机制(S)。目的1优化所有小分子热休克蛋白(SHSP)的原型--人?B晶体蛋白的功能。功能分析将被用来表征新的晶状体蛋白突变体在应激反应中的作用以及对体外蛋白质展开和聚集的保护作用。目的2将使用裂隙灯成像技术对神经退行性疾病和神经肌肉疾病转基因小鼠模型的晶状体进行表型分析。这一目标解决了假设2:晶状体透明度的丧失是神经退行性疾病和神经肌肉疾病中蛋白质相互作用改变的敏感指标。晶状体用于非侵入性光学检查的独特可及性使晶状体细胞成为研究活体动物聚集和淀粉样蛋白形成的基本机制的极佳工具。假设3:神经退行性变中导致晶状体表型的蛋白质也可能与神经肌肉疾病中的晶状体表型有关,AIM 3将在神经退行性疾病和神经肌肉疾病的转基因小鼠模型中确定负责结构表型的关键蛋白质成分。使用激光捕获显微解剖(LCM)获得的样品的质谱学将与免疫细胞化学以及光学和电子显微镜相结合,以将蛋白质成分与结构修饰联系起来,考虑到在神经退行性疾病和神经肌肉疾病小鼠模型的晶状体中观察到的表型。对公众健康的意义:蛋白质展开和淀粉样蛋白/聚集体的形成是老年性疾病的特征,包括白内障、老年性黄斑变性(AMD)、神经变性、心肌病和肌营养不良。随着人类寿命的延长,老年性疾病的影响也在急剧增加。确定应激蛋白B保护活性的基本机制将是生物医学研究的重大进展,并有可能为衰老疾病提供新的治疗靶点。该晶状体是体内研究βB晶体蛋白功能的理想材料,可作为神经退行性疾病和神经肌肉疾病发生和发展的生物标志物。公共卫生相关性:这项应用是对应激蛋白人类B晶体蛋白的相互作用的研究,该蛋白负责防止蛋白质展开和聚集的基本保护机制(S)。该方法是在体外表征相互作用区域的活性并量化它们的亲和力,同时使用裂隙灯在体内研究它们对晶状体透明结构的影响。这些结果将推动生物医学研究,了解SHSP在神经退行性疾病、心血管疾病、肌营养不良症、AMD(老年性黄斑营养不良)和白内障等老年性疾病中的内源性功能。这项研究具有翻译应用于开发针对主要衰老疾病的新疗法的潜力。这种透镜被用于这些研究,是因为它可以在体内研究衰老过程中蛋白质展开和聚集疾病,以及众所周知的?B晶状体蛋白的保护作用。
英文摘要
DESCRIPTION (provided by applicant): The primary objective of the proposed research is to define the functional mechanism for the protective actions of the stress protein, human ?B crystallin, a small heat shock protein (sHSP) and molecular chaperone. HYPOTHESIS 1: The activity of multiple interactive sequences in human??B crystallin provides protection against protein unfolding, aggregation, and toxicity in aging disorders that include cataract, neurodegeneration, AMD, and possibly, neuromuscular disorders. Synthetic peptides based on the individual interactive domains in ?B crystallin mediate the formation of amyloid fibrils and will be used to characterize the collective mechanism(s) of the interactive domains in the action of ?B crystallin. AIM 1 will optimize the function of human ?B crystallin, the archetype of all small heat shock proteins (sHSP). Functional assays will be used to characterize the effects of new mutants of ?B crystallin on the stress response and protection against protein unfolding and aggregation in vitro. AIM 2 will use slit lamp imaging to conduct phenotype analyses of lenses in transgenic mouse models for neurodegenerative and neuromuscular disorders. This aim addresses HYPOTHESIS 2: The loss of lens transparency is a sensitive indicator of altered protein interactions in neurodegenerative and neuromuscular disorders. The unique accessibility of the lens for non-invasive optical examinations makes lens cells excellent for the study of basic mechanisms of aggregation and amyloid formation in living animals. HYPOTHESIS 3: The proteins responsible for the lens phenotype in neurodegeneration may also be responsible for the lens phenotype in neuromuscular disorders, and AIM 3 will identify critical protein constituents responsible for the structural phenotype in transgenic mouse models for neurodegenerative and neuromuscular disorders. Mass spectrometry of samples obtained using laser capture microdissection (LCM) will be combined with immunocytochemistry, and light and electron microscopy to correlate protein constituents with structural modifications accounting for the phenotype observed in lenses of mouse models for neurodegenerative and neuromuscular disorders. SIGNIFICANCE FOR PUBLIC HEALTH: Protein unfolding and amyloid/aggregate formation characterize disorders of aging that include cataract, age related macular degeneration (AMD), neurodegeneration, cardiomyopathy and muscular dystrophy. With the increase in human longevity, the impact of aging diseases is increasing dramatically. Defining the basic mechanism for the protective activity of the stress protein ?B crystallin will be a major advance in biomedical research and has the potential to provide novel therapeutic targets for aging disorders. The lens is ideal for innovative functional studies of ?B crystallin function in vivo and may have significance as a biomarker for the initiation and progression of neurodegenerative and neuromuscular disease. PUBLIC HEALTH RELEVANCE: This application is a study of the interactions of the stress protein human ?B crystallin responsible for the fundamental protective mechanism(s) against protein unfolding and aggregation. The approach is to characterize the activity of the interactive domains and quantify their affinities in vitro while studying their influence on the transparent structure of the lens in vivo using the slit lamp. The results will advance biomedical research in understanding the endogenous function of sHSP in diseases of aging that include neurodegeneration, cardiovascular diseases, muscular dystrophy, AMD (age related macular dystrophy) and cataract. This research has the potential for translational applications to the development of novel therapeutics against major diseases of aging. The lens is used for these studies because of its unique accessibility for the in vivo investigation of protein unfolding and aggregation diseases in aging and the well known protective effects of ?B crystallin.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
LSM Confocal System
-
批准号:7044755
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2006
-
负责人:JOHN Irwin CLARK
-
依托单位:
LSM CONFOCAL SYSTEM: EYE AND VISION
-
批准号:7335234
-
项目类别:
-
资助金额:$17.5万
-
财政年份:2006
-
负责人:JOHN Irwin CLARK
-
依托单位:
LSM CONFOCAL SYSTEM: DEVELOPMENTAL BIOLOGY
-
批准号:7335233
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2006
-
负责人:JOHN Irwin CLARK
-
依托单位:
LSM CONFOCAL SYSTEM: HEARING
-
批准号:7335235
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2006
-
负责人:JOHN Irwin CLARK
-
依托单位:
SPARC and the Differentiation of Transparent Lens Fibers
-
批准号:6888079
-
项目类别:
-
资助金额:$27.34万
-
财政年份:2001
-
负责人:JOHN Irwin CLARK
-
依托单位:
SPARC and the Differentiation of Transparent Lens Fibers
-
批准号:6635717
-
项目类别:
-
资助金额:$27.34万
-
财政年份:2001
-
负责人:JOHN Irwin CLARK
-
依托单位:
SPARC and the Differentiation of Transparent Lens Fibers
-
批准号:6738986
-
项目类别:
-
资助金额:$27.34万
-
财政年份:2001
-
负责人:JOHN Irwin CLARK
-
依托单位:
SPARC and the Differentiation of Transparent Lens Fibers
-
批准号:6326795
-
项目类别:
-
资助金额:$28.68万
-
财政年份:2001
-
负责人:JOHN Irwin CLARK
-
依托单位:
SPARC and the Differentiation of Transparent Lens Fibers
-
批准号:6518699
-
项目类别:
-
资助金额:$27.34万
-
财政年份:2001
-
负责人:JOHN Irwin CLARK
-
依托单位:
INSTRUMENTATION
-
批准号:3003309
-
项目类别:
-
资助金额:$6.75万
-
财政年份:1985
-
负责人:JOHN Irwin CLARK
-
依托单位:
DEVELOPMENT AND MAINTENANCE OF LENS TRANSPARENCY
-
批准号:2159089
-
项目类别:
-
资助金额:$26.82万
-
财政年份:1982
-
负责人:JOHN Irwin CLARK
-
依托单位:
DEVELOPMENT AND MAINTENANCE OF LENS TRANSPARENCY
-
批准号:6518316
-
项目类别:
-
资助金额:$38.34万
-
财政年份:1982
-
负责人:JOHN Irwin CLARK
-
依托单位:
DEVELOPMENT AND MAINTENANCE OF TRANSPARENCY IN LENSES
-
批准号:3258957
-
项目类别:
-
资助金额:$19.18万
-
财政年份:1982
-
负责人:JOHN Irwin CLARK
-
依托单位:
DEVELOPMENT AND MAINTENANCE OF TRANSPARENCY IN LENSES
-
批准号:3258960
-
项目类别:
-
资助金额:$13.5万
-
财政年份:1982
-
负责人:JOHN Irwin CLARK
-
依托单位:
DEVELOPMENT AND MAINTENANCE OF TRANSPARENCY IN LENSES
-
批准号:3258959
-
项目类别:
-
资助金额:$11.49万
-
财政年份:1982
-
负责人:JOHN Irwin CLARK
-
依托单位:
Development and Maintenance of Lens Transparency
-
批准号:6805269
-
项目类别:
-
资助金额:$54.29万
-
财政年份:1982
-
负责人:JOHN Irwin CLARK
-
依托单位:
Development and Maintenance of Lens Transparency
-
批准号:7269860
-
项目类别:
-
资助金额:$56.92万
-
财政年份:1982
-
负责人:JOHN Irwin CLARK
-
依托单位:
Development and Maintenance of Lens Transparency
-
批准号:7685758
-
项目类别:
-
资助金额:$6.9万
-
财政年份:1982
-
负责人:JOHN Irwin CLARK
-
依托单位:
DEVELOPMENT AND MAINTENANCE OF LENS TRANSPARENCY
-
批准号:2159090
-
项目类别:
-
资助金额:$27.68万
-
财政年份:1982
-
负责人:JOHN Irwin CLARK
-
依托单位:
DEVELOPMENT AND MAINTENANCE OF LENS TRANSPARENCY
-
批准号:3258963
-
项目类别:
-
资助金额:$21.75万
-
财政年份:1982
-
负责人:JOHN Irwin CLARK
-
依托单位:
海外基金